BCGM Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.51M Sell
4,909
-21
-0.4% -$21.3K 1.13% 28
2025
Q4
$5.3M Buy
4,930
+3
+0.1% +$2.87K 1.35% 22
2025
Q3
$3.76M Buy
4,927
+126
+3% +$93.8K 0.98% 33
2025
Q2
$3.74M Buy
4,801
+100
+2% +$77.7K 1.06% 34
2025
Q1
$3.88M Buy
4,701
+1
+0% +$832 1.19% 24
2024
Q4
$3.63M Buy
4,700
+585
+14% +$484K 1.15% 25
2024
Q3
$3.65M Buy
4,115
+2
+0% +$1.8K 1.18% 25
2024
Q2
$3.72M Buy
4,113
+163
+4% +$130K 1.29% 23
2024
Q1
$3.07M Buy
3,950
+14
+0.4% +$9.96K 1.1% 26
2023
Q4
$2.29M Sell
3,936
-204
-5% -$119K 0.93% 31
2023
Q3
$2.22M Buy
4,140
+19
+0.5% +$9.79K 1.02% 29
2023
Q2
$1.93M Buy
4,121
+1,184
+40% +$497K 0.85% 31
2023
Q1
$1.01M Sell
2,937
-1,120
-28% -$378K 0.51% 49
2022
Q4
$1.48M Buy
4,057
+9
+0.2% +$3.19K 0.72% 36
2022
Q3
$1.44M Buy
4,048
+213
+6% +$67.5K 0.72% 36
2022
Q2
$1.26M Sell
3,835
-17
-0.4% -$5.1K 0.64% 33
2022
Q1
$1.13M Buy
3,852
+1
+0% +$257 0.61% 39
2021
Q4
$1.06M Hold
3,851
0.57% 42
2021
Q3
$981K Buy
3,851
+18
+0.5% +$4.44K 0.55% 45
2021
Q2
$933K Sell
3,833
-55
-1% -$11K 0.55% 42
2021
Q1
$741K Sell
3,888
-53
-1% -$10.4K 0.51% 46
2020
Q4
$817K Buy
+3,941
New +$588K 0.58% 33

Other funds holding LLY

BCGM Wealth Management's LLY Position: Q1 2026 in Review

BCGM Wealth Management reduced its Eli Lilly (LLY) stake by 0.43% in Q1 2026, selling an estimated $21.3K and leaving 4,909 shares worth $4.51M. The position accounts for 1.13% of the portfolio, ranked #28.

BCGM Wealth Management first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.3M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BCGM Wealth Management held 4,909 shares of Eli Lilly worth $4.51M as of Q1 2026.
  • BCGM Wealth Management sold 21 Eli Lilly shares in Q1 2026, an estimated $21.3K.
  • Eli Lilly made up 1.13% of BCGM Wealth Management's portfolio in Q1 2026, its #28 holding.
  • BCGM Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • BCGM Wealth Management's Eli Lilly position peaked at $5.3M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BCGM Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.